Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with E
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q4 2022 | ETHYLCELLULOSE (10 MPA.S) | ORAL | LIQUID, EXTENDED RELEASE | 4.17 mg/ 1.00 ml | 50mg | Deletion | |
| Q4 2022 | ETHYLCELLULOSE (20 MPA.S) | ORAL | POWDER | 298.50 mg | Deletion | ||
| Q3 2022 | EDETATE CALCIUM DISODIUM | INTRAVENOUS | INJECTION | 2.16 mg | MDE Replacement | ||
| Q4 2022 | EDETATE CALCIUM DISODIUM | INTRAVENOUS | INJECTION | 23mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: October 1, 2022
Database Last Updated: October 19, 2022